Skip to main content

Publisher: Elsevier

Volume 206, Number 2, 15 February 2003

Editorial Board
pp. CO2-CO2(1)

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Clinical-MRI correlations in the secondary progressive phase of MS: lessons from the treatment trials
pp. 139-144(6)
Authors: Clanet, M.; Cassol, E.; Manelfe, C.; Berry, I.

Favourites:
ADD

The diagnosis of primary progressive multiple sclerosis
pp. 145-152(8)
Authors: Wolinsky, J.S.; the PROMiSe Study Group

Favourites:
ADD

Primary and secondary progressive multiple sclerosis
pp. 153-155(3)
Authors: Vukusic, S.; Confavreux, C.

Favourites:
ADD
Favourites:
ADD

Differences between subgroups of MS: MRI findings and correlation with histopathology
pp. 173-174(2)
Authors: Lycklama a Nijeholt, G.; Barkhof, F.

Favourites:
ADD

Remyelination in multiple sclerosis
pp. 181-185(5)
Authors: Bruck, W.; Kuhlmann, T.; Stadelmann, C.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis
pp. 209-214(6)
Authors: Petereit, H.F.; Pukrop, R.; Fazekas, F.; Bamborschke, S.U.; Ropele, S.; Kolmel, H.W.; Merkelbach, S.; Japp, G.; Jongen, P.J.H.; Hartung, H.P.; Hommes, O.R.

Favourites:
ADD

Interferon beta-1a in primary progressive multiple sclerosis
pp. 215-216(2)
Authors: Leary, S.M.; Thompson, A.J.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more